NCT03516318 (Y-SMART) is a NA clinical trial of SMART Connections in Human Immunodeficiency Virus, sponsored by FHI 360.

Who is sponsoring NCT03516318?

NCT03516318 is sponsored by FHI 360.

What drugs are being tested in NCT03516318?

Interventions in NCT03516318: SMART Connections.

What condition does NCT03516318 study?

NCT03516318 studies Human Immunodeficiency Virus.

Is NCT03516318 still recruiting?

NCT03516318 is currently terminated. Last updated 13 April 2020.

Last reviewed 2020-04-13 · How we verify

NCT03516318: Y-SMART

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Using Social Media to Improve ART Retention and Treatment Outcomes Among YLHIV in Nigeria

Terminated NA Last updated 13 April 2020

What this trial tests

NA trial testing SMART Connections in Human Immunodeficiency Virus in 355 participants. Terminated before completion.

Timeline

4 September 2018

Primary endpoint
30 November 2019

30 November 2019

Quick facts

Lead sponsor	FHI 360
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	355
Start date	4 September 2018
Primary completion	30 November 2019
Estimated completion	30 November 2019
Sites	1 location across Nigeria

Drugs / interventions tested

SMART Connections

Conditions studied

Human Immunodeficiency Virus — all drugs for Human Immunodeficiency Virus →

Sponsor

FHI 360 — full company profile →

Who can join

Adults 15 to 24, any sex, with Human Immunodeficiency Virus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A randomized control trial to test the effectiveness of a structured online support group, SMART (Social Media to improve ART Retention in Treatment) Connections, to improve retention in HIV care services among youth living with HIV (YLHIV) in Nigeria.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

A Social Media-Based Support Group for Youth Living With HIV in Nigeria (SMART Connections): Randomized Controlled Trial.
Dulli L, Ridgeway K, Packer C, Murray KR, et al · · 2020 · cited 53× · PMID 32484444 · DOI 10.2196/18343
Antiretroviral adherence for adolescents growing up with HIV: understanding real life, drug delivery and forgiveness.
Foster C, Ayers S, Fidler S. · · 2020 · cited 30× · PMID 32523693 · DOI 10.1177/2049936120920177

Verify or expand the search:

Other recruiting trials for Human Immunodeficiency Virus

Currently open trials in the same condition.

NCT07530198 — HIV Therapeutic DNA Vaccine (ICVAX) Phase I Clinical Trial in Hong Kong · Phase 1 · recruiting
NCT06819176 — Lenacapavir Intensification to Disrupt HIV Reservoirs in Virologically Suppressed People With HIV Receiving Antiretrovir · Phase 1 · recruiting
NCT06408142 — Universal Test and Connect for HIV Service Delivery in South Africa · recruiting
NCT07101458 — The Eswatini PRISM Study on Adolescents Living With HIV · NA · recruiting
NCT06554223 — The SUSTAIN 2 Study - SUStained HIV Treatment for Adherence After Interruption in Care · NA · recruiting

Other FHI 360 trials

Trials by the same sponsor.

NCT05233956 — Levonorgestrel Intrauterine System Effects on Hemoglobin and Serum Ferritin Among Anemic Women in Kenya · NA · active not recruiting
NCT05937698 — The CATALYST Study · terminated
NCT05889533 — Eswatini Ring Study: Increasing PrEP Options for Women · terminated
NCT05016895 — REACH2: Implementation Research on Bi-Annual Mass Distribution of Azithromycin to Children 1-11 Months in Côte d'Ivoire · NA · completed
NCT04617626 — Resiliency Through Azithromycin for Children (REACH), Côte d'Ivoire · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03516318 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by FHI 360
Last refreshed: 13 April 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03516318.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing